Skip to content
Homepage
Author:
Zomedica Corp.
Posted Date:
November 4, 2026
Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Zomedica Corp.
November 4, 2026
Zomedica Announces “Fourth Friday at Four” Webinar on October 23, 2026: Zomedica’s Clinical Program: How Evidence Drives Adoption
Zomedica Corp.
October 8, 2026
Zomedica Announces Strategic Partnership with Veterinary Study Groups (VMG) to Deliver Advanced Veterinary Technologies to Independent Practices
Zomedica Corp.
September 22, 2026
Zomedica Announces “Fourth Friday at Four” Webinar on September 25, 2026: Inside Zomedica’s Marketing Engine: How Demand Becomes Revenue
Zomedica Corp.
September 9, 2026
Zomedica Announces Strategic Collaboration with Boehringer Ingelheim Animal Health Canada Inc. to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA(R) Platform
Zomedica Corp.
August 18, 2026
